SCHEMBL23367190

SCHEMBL23367190

CC(C)(C)OC(=O)NCC1(c2ccncc2)NC(=O)NC1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP13 P45452 3/20 0.43
MMP14 P50281 3/20 0.43
MMP8 P22894 1/20 0.43
CYP17A1 P05093 1/20 0.39
ADAMTS7 Q9UKP4 8/20 0.38
ADAMTS5 Q9UNA0 4/20 0.37
ADAMTS4 O75173 3/20 0.37
ADAM17 P78536 3/20 0.37
MMP2 P08253 2/20 0.37
MMP3 P08254 2/20 0.37
LATS1 O95835 2/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
CYP3A4 P08684 1/20 0.36
LATS2 Q9NRM7 1/20 0.36
MMP1 P03956 1/20 0.35
MMP7 P09237 1/20 0.35
MMP9 P14780 1/20 0.35
ADAM10 O14672 1/20 0.35
MMP12 P39900 1/20 0.35
MMP15 P51511 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29873860 1.00 MMP13 (0.43) MMP13MMP14MMP8CYP17A1ADAMTS7
SCHEMBL29874400 0.86 CYP3A4 (0.52) MMP13ADAMTS5ADAMTS4ADAM17MMP2
SCHEMBL24938581 0.86 CYP3A4 (0.52) MMP13ADAMTS5ADAMTS4ADAM17MMP2
SCHEMBL14978283 0.86 NPC1 (0.39) MMP13MMP14ADAMTS5ADAMTS4ADAM17
SCHEMBL5955565 0.86 MMP14 (0.40) MMP13MMP14ADAMTS7ADAMTS5ADAMTS4
SCHEMBL5955764 0.84 ADAM17 (0.44) MMP13MMP14ADAMTS5ADAMTS4ADAM17
SCHEMBL23354936 0.81 MMP13 (0.49) MMP13MMP14MMP8ADAMTS5ADAMTS4
SCHEMBL23354123 0.81 ADAMTS5 (0.46) MMP13MMP14ADAMTS7ADAMTS5ADAMTS4
SCHEMBL24927817 0.81 ADAM17 (0.41) MMP13MMP14ADAMTS7ADAMTS5ADAMTS4
SCHEMBL29978673 0.81 ADAM17 (0.41) MMP13MMP14ADAMTS7ADAMTS5ADAMTS4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230027985-A1 SUBSTITUTED HYDANTOINAMIDES AS ADAMTS7 ANTAGONISTS BAYER AKTIENGESELLSCHAFT (DE) 2023-01-26 US disclosed
EP-3822265-A1 SUBSTITUTED HYDANTOINAMIDES AS ADAMTS7 ANTAGONISTS Bayer AG (DE) 2021-05-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230027985-A1 SUBSTITUTED HYDANTOINAMIDES AS ADAMTS7 ANTAGONISTS ADAMTS7, MMP7, ADAMTS1 MMP13 40/4885MMP14 16/4885MMP8 50/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.